Boehringer Ingelheim Pharmaceuticals, Inc. recalls Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuti…
- Recall date
- September 22, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0007-2018
- FDA classification
- Class III
- Brand / firm
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Sold / distributed
- CO, OH
Why it was recalled
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Get recall alerts
Free email alert whenever Boehringer Ingelheim Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Boehringer Ingelheim Pharmaceuticals, Inc.